TITLE

Once-Weekly Fluoxetine: A Viewpoint by William J. Burke

AUTHOR(S)
Burke, W.J.
PUB. DATE
December 2001
SOURCE
Drugs;Dec2001, Vol. 61 Issue 15, p2229
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Comments on the use fluoxetine for the treatment of depression. Half-life of norfluoxetine; Adverse effects of the drug; Administration of the drug on a weekly basis.
ACCESSION #
5692974

 

Related Articles

  • Don't feel bad. Laliberte, Richard // Men's Health;Mar94, Vol. 9 Issue 2, p74 

    Focuses on drugs which can lift depression. Prozac; Side effects; The neurotransmitter serotonin; Tricyclics; Monoamine oxidase inhibitors; Zoloft, Paxil, Wellbutrin; Details.

  • SEEKING THE WIZARDS OF PROZAC. Thompson, Tracy // Saturday Evening Post;Mar/Apr94, Vol. 266 Issue 2, p50 

    Discusses the role of the drug Prozac or fluoxetine in treating depression. Eli Lilly and Company as manufacturers; Sales in 1992; Lawsuits against Lilly claiming Prozac as cause of homicidal or suicidal impulses; Treatment of melancholia in ancient Greece; Author's manic depression; Ray...

  • Fluoxetine. Gram, Lars F. // New England Journal of Medicine;11/17/94, Vol. 331 Issue 20, p1354 

    Summarizes the published information about fluoxetine (Prozac). Pharmacodynamics; Pharmacokinetics; Clinical indications; Dose-effect studies and the treatment of depression; Comparison with imipramine; Methodologic problems in studies of depression; Tolerability and adverse effects; Other aspects.

  • Singing the Prozac blues. Brink, Susan // U.S. News & World Report;11/8/93, Vol. 115 Issue 18, p76 

    Focuses on the antidepressant Prozac and the drug's reputation which has gone through wild mood swings. Prozac was the first of a radically new class of antidepressants called selective serotonin-reuptake inhibitors (SSRI); The advantage over earlier classes called tricyclics; Underestimated or...

  • GETTING PAST PROZAC. Graves, Ginny // Harper's Bazaar;May2000, Issue 3462, p100 

    Investigates the use of prozac in treating depression among women and offers tips on when to stop using the drug.

  • New Statistical Proposals to Evaluate the Benefit/Risk Ratio of Long-Term Treatment of Depression: Application to a One-Year Double-Blind Study Comparing Medifoxamine with Fluoxetine. Lehert, P.; Poirier-Littre, M.F.; Pringuey, D.; Galinowski, A. // Clinical Drug Investigation;1998, Vol. 15 Issue 4, p285 

    The aim of this study was to determine the benefit/risk ratio of long-term treatment with medifoxamine, a non-tricyclic, non-monoamine oxidase inhibitor agent, and fluoxetine in patients with acute depressive episode and at high risk of relapse and/or recurrence. The study involved a 12-month...

  • Fluoxetine: A Review of its Use in Anxiety Disorders and Mixed Anxiety and Depression. Hurst, M.; Lamb, H.M. // CNS Drugs;2000, Vol. 14 Issue 1, p51 

    Fluoxetine is a selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitor (SSRI). Although its mechanism of action in anxiety disorders is unclear, it is thought to act by enhancing serotonergic neurotransmission and down-regulating central receptors. In comparison with other SSRIs,...

  • Get `the blues' with music--let St. John's Wort have the other kind. Quinn, Shannon // Better Nutrition;Sep97, Vol. 59 Issue 9, p30 

    Presents information on depression, while highlighting the use of Prozac, a brand of fluoxetine, for the condition. Information on Prozac; Details on Prozac sales in 1996; Accomplishments of the dietary supplement St. John's Wort, in treating depression; Views of Doctor Michael T. Murray, author...

  • New, improved.  // Health (Time Inc. Health);Apr98, Vol. 12 Issue 3, p40 

    Discusses the effectiveness of the drug Serzone, as compared with Prozac or other drugs, on relieving depression.

  • Mirtazapine is More Effective for Depression Beginning at 3 Weeks.  // Modern Medicine;Oct98, Vol. 66 Issue 10, p14 

    Discusses the abstract of the article `Efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder,' by D.P. Wheatley, M. Moffaert et al, published in the July 1998 issue of the `Journal of Clinical Psychiatry' periodical.

Share

Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics